https://www.selleckchem.com/pr....oducts/pkm2-inhibito
nd CHD. These findings indicate the promise of IPH as a marker of plaque vulnerability in healthy persons with subclinical atherosclerosis. Treatment of aortic-valve disease in young patients still poses challenges. The Ross procedure offers several potential advantages that may translate to improved long-term outcomes. This study reports long-term outcomes after the Ross procedure. Adult patients who were included in the Ross Registry between 1988 and 2018 were analyzed. Endpoints were overall survival, reinterventio
Like
Comment
Share
